JP2004504327A - 心血管疾患に関するペプチドおよびそのアッセイにおけるそれらの使用 - Google Patents

心血管疾患に関するペプチドおよびそのアッセイにおけるそれらの使用 Download PDF

Info

Publication number
JP2004504327A
JP2004504327A JP2002512214A JP2002512214A JP2004504327A JP 2004504327 A JP2004504327 A JP 2004504327A JP 2002512214 A JP2002512214 A JP 2002512214A JP 2002512214 A JP2002512214 A JP 2002512214A JP 2004504327 A JP2004504327 A JP 2004504327A
Authority
JP
Japan
Prior art keywords
peptide
peptide according
sample
mda
peptides
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
JP2002512214A
Other languages
English (en)
Japanese (ja)
Other versions
JP2004504327A5 (https=
Inventor
オウティ・ナルヴァネン
セッポ・ユラ−ヘルッチュアラ
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Ark Therapeutics Oy
Original Assignee
Ark Therapeutics Oy
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ark Therapeutics Oy filed Critical Ark Therapeutics Oy
Publication of JP2004504327A publication Critical patent/JP2004504327A/ja
Publication of JP2004504327A5 publication Critical patent/JP2004504327A5/ja
Withdrawn legal-status Critical Current

Links

Images

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/775—Apolipopeptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Toxicology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
JP2002512214A 2000-07-18 2001-07-18 心血管疾患に関するペプチドおよびそのアッセイにおけるそれらの使用 Withdrawn JP2004504327A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB0017641.2A GB0017641D0 (en) 2000-07-18 2000-07-18 Peptides and their use
PCT/GB2001/003212 WO2002006314A2 (en) 2000-07-18 2001-07-18 Peptides and their use in assays for cardiovascular disease

Publications (2)

Publication Number Publication Date
JP2004504327A true JP2004504327A (ja) 2004-02-12
JP2004504327A5 JP2004504327A5 (https=) 2008-09-04

Family

ID=9895897

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2002512214A Withdrawn JP2004504327A (ja) 2000-07-18 2001-07-18 心血管疾患に関するペプチドおよびそのアッセイにおけるそれらの使用

Country Status (12)

Country Link
US (2) US20040091934A1 (https=)
EP (1) EP1301537B1 (https=)
JP (1) JP2004504327A (https=)
AT (1) ATE408626T1 (https=)
AU (1) AU2001270851A1 (https=)
CA (1) CA2417789A1 (https=)
DE (1) DE60135846D1 (https=)
DK (1) DK1301537T3 (https=)
ES (1) ES2312455T3 (https=)
GB (1) GB0017641D0 (https=)
PT (1) PT1301537E (https=)
WO (1) WO2002006314A2 (https=)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2010515023A (ja) * 2006-12-22 2010-05-06 アボット・ラボラトリーズ 心血管系自己免疫疾患パネルおよびその使用方法
JP2013040781A (ja) * 2011-08-11 2013-02-28 Nec Corp 心疾患診断マーカー

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030105003A1 (en) 2001-04-05 2003-06-05 Jan Nilsson Peptide-based immunization therapy for treatment of atherosclerosis and development of peptide-based assay for determination of immune responses against oxidized low density lipoprotein
SE0103754L (sv) * 2001-04-05 2002-10-06 Forskarpatent I Syd Ab Peptider från apolipoprotein B, användning därav immunisering, diagnosmetod eller terapeutisk behandling av ischemiska kardiovaskulära sjukdomar, samt farmaceutisk komposition och vaccin innehållande sådan peptid
AU2002362612B2 (en) 2001-09-28 2007-11-15 Cedars-Sinai Medical Center Prevention and treatment of restenosis by local administration of drug
JP2007531537A (ja) 2004-04-06 2007-11-08 セダーズ−シナイ　メディカル　センター アポリポタンパク質ａ−ｉおよびアポリポタンパク質ａ−ｉｍｉｌａｎｏをコードする組換えアデノ随伴ウイルスベクターによる血管疾患の予防および処置
US7776605B2 (en) * 2006-10-26 2010-08-17 Abbott Laboratories Assay for cardiac troponin autoantibodies
US20080305512A1 (en) * 2006-10-26 2008-12-11 Mattingly Phillip G Assay for cardiac troponin autoantibodies
MX2009004460A (es) * 2006-10-26 2009-07-09 Abbott Lab Inmunoensayo de analitos en muestras que contienen anticuerpos anti-analito endogenos.
RU2013126628A (ru) 2010-11-12 2014-12-20 Седарс-Синаи Медикал Сентер Иммуномодулирующие способы и системы для лечения и/или предотвращения аневризм
CA2817543A1 (en) 2010-11-12 2012-06-07 Cedars-Sinai Medical Center Immunomodulatory methods and systems for treatment and/or prevention of hypertension
CN107085025B (zh) * 2016-02-15 2019-09-17 太原师范学院 一种自组装三层膜电极及其制备方法和用途
EP3463416A1 (en) 2016-05-31 2019-04-10 CardioVax, LLC Methods for diagnosing and treating systemic lupus erythematosus
US10858422B2 (en) 2016-05-31 2020-12-08 Abcentra, Llc Methods for treating systemic lupus erythematosus with an anti-apolipoprotein B antibody
CN111855986A (zh) * 2019-04-25 2020-10-30 常州博闻迪医药股份有限公司 联合定量检测五项心脏标志物试剂盒及制备方法

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5408038A (en) * 1991-10-09 1995-04-18 The Scripps Research Institute Nonnatural apolipoprotein B-100 peptides and apolipoprotein B-100-apolipoprotein A-I fusion peptides
GB9609702D0 (en) * 1996-05-09 1996-07-10 Royal Free Hosp School Med Anticoagulant peptides
GB9705831D0 (en) * 1997-03-20 1997-05-07 Univ Leicester Oxidised ldl
US6635623B1 (en) * 1997-06-13 2003-10-21 Baylor College Of Medicine Lipoproteins as nucleic acid vectors
WO1998059248A1 (en) * 1997-06-20 1998-12-30 Leuven Research & Development Vzw Assays, antibodies, and standards for detection of oxidized and mda-modified low density lipoproteins

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2010515023A (ja) * 2006-12-22 2010-05-06 アボット・ラボラトリーズ 心血管系自己免疫疾患パネルおよびその使用方法
JP2013040781A (ja) * 2011-08-11 2013-02-28 Nec Corp 心疾患診断マーカー

Also Published As

Publication number Publication date
ES2312455T3 (es) 2009-03-01
GB0017641D0 (en) 2000-09-06
ATE408626T1 (de) 2008-10-15
AU2001270851A1 (en) 2002-01-30
DK1301537T3 (da) 2008-12-08
PT1301537E (pt) 2008-12-04
WO2002006314A3 (en) 2002-04-18
EP1301537B1 (en) 2008-09-17
CA2417789A1 (en) 2002-01-24
DE60135846D1 (de) 2008-10-30
EP1301537A2 (en) 2003-04-16
US20040091934A1 (en) 2004-05-13
US20080261234A1 (en) 2008-10-23
WO2002006314A2 (en) 2002-01-24

Similar Documents

Publication Publication Date Title
US20080261234A1 (en) Peptides and their use in assays for cardiovascular disease
JP4197743B2 (ja) リューマチ様の関節炎の患者からの自己抗体により認識される抗原から誘導されたペプチド、前記ペプチドを指向する抗体、抗原及び自己免疫抗体を検出する方法
Dac et al. A selective bi-site immunoenzymatic procedure for human Lp [a] lipoprotein quantification using monoclonal antibodies against apo [a] and apoB.
WO2012175602A2 (en) Elisa for calprotectin
CN104991077A (zh) 肌钙蛋白i竞争比浊法检测试剂盒
EP3649145A1 (en) Improved rep protein for use in a diagnostic assay
CN105137071B (zh) 心肌肌钙蛋白i均相酶免疫法测定试剂盒
JP5747315B2 (ja) 糖鎖不全ヒトＩｇＡ１ヒンジ部を認識する抗体及びその用途
Osman et al. A sensitive time-resolved immunofluorometric assay for the measurement of apolipoprotein B in cerebrospinal fluid. Application to multiple sclerosis and other neurological diseases
JPH09104699A (ja) 血清アミロイドａを認識する抗体
WO1992012429A1 (en) Highly sensitive assay of tissue factor and kit therefor
JP3445373B2 (ja) 血清アミロイドａの免疫学的測定法
EP0410004A1 (en) Immunoassay of human osteocalcin, reagent and kit therefor
JP4280236B2 (ja) 生体内の酸化ＬＤＬ−β２−グリコプロテインＩ複合体の測定方法
EP0301667A1 (en) Method for the immunoassay of apolipoproteins
WO1999064868A1 (fr) Nouveau procede de dosage de la troponine i cardiaque
WO2017033281A1 (ja) 特異的に精製された抗プレセプシン抗体
WO1997006184A1 (fr) Anticorps reconnaissant l'amyloide a serique
Matikainen et al. Demonstration of the Predominant Urine Osteocalcin Fragments Detectable by Two‐Site Immunoassays
WO2004074833A1 (ja) 酸化ｌｄｌ－ｃｒｐ複合体の測定方法及び測定キット
JP4203878B2 (ja) モノクローナル抗体を用いるヒト血漿型ｐａｆ−ａｈの検出方法
CN1660893A (zh) 一种人心肌肌钙蛋白i合成肽段s28－42及其用途
WO2009114875A2 (en) Oxidized paraoxonase 1 and paraoxonase 1/hdl particle number ratio as risk markers for cardiovascular disease
Sato et al. Enzyme-linked immunosorbent assay for cholesteryl ester transfer protein in human serum
JP6581274B1 (ja) 肝疾患の検査方法、その検査キット及びコンパニオン診断薬

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20080716

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20080716

A761 Written withdrawal of application

Free format text: JAPANESE INTERMEDIATE CODE: A761

Effective date: 20100325

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A821

Effective date: 20100325